Insider Buying: GE HealthCare Technologies (NASDAQ:GEHC) Director Buys $63,010.00 in Stock

GE HealthCare Technologies Inc. (NASDAQ:GEHC) Director Watkin Phoebe Yang bought 1,000 shares of the business’s stock in a transaction on Friday, May 8th. The stock was purchased at an average price of $63.01 per share, for a total transaction of $63,010.00. Following the purchase, the director directly owned 13,702 shares in the company, valued at approximately $863,363.02. This represents a 7.87% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink.

GE HealthCare Technologies Trading Down 0.6%

NASDAQ GEHC opened at $61.89 on Thursday. The stock has a market capitalization of $28.15 billion, a price-to-earnings ratio of 14.81, a PEG ratio of 1.40 and a beta of 0.74. The stock’s 50 day moving average price is $70.26 and its two-hundred day moving average price is $76.95. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in GEHC. Godsey & Gibb Inc. bought a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Laurel Wealth Advisors LLC bought a new position in shares of GE HealthCare Technologies during the 4th quarter worth approximately $26,000. Optima Capital LLC bought a new position in shares of GE HealthCare Technologies during the 4th quarter worth approximately $27,000. Godfrey Financial Associates Inc. bought a new position in shares of GE HealthCare Technologies during the 4th quarter worth approximately $27,000. Finally, Montag A & Associates Inc. boosted its stake in shares of GE HealthCare Technologies by 105.4% during the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after acquiring an additional 175 shares during the period. 82.06% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have commented on GEHC shares. Morgan Stanley boosted their target price on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 4th. Citigroup lowered their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research report on Thursday, April 30th. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. The Goldman Sachs Group lowered GE HealthCare Technologies from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $81.00 to $65.00 in a research report on Thursday, April 30th. Finally, UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and boosted their price target for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. Eight investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $80.67.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.